Effect of drug-induced ascorbic acid release in the striatum and the nucleus accumbens in hippocampus-lesioned rats

Brain Research

Volumn 1125, Issue 1, 2006, Pages 163-170

  Dai, Fang ^a   Yang, Jing Yu ^a   Gu, Pei Fei ^a   Hou, Yue ^a   Wu, Chun Fu ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Ascorbic acid; Ethanol; Methamphetamine; Morphine; Nucleus accumben; Striatum

Indexed keywords

ALCOHOL; ASCORBIC ACID; METHAMPHETAMINE; MORPHINE; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG DEPENDENCE; ELECTROCHEMICAL DETECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ANALYSIS OF VARIANCE; ANIMALS; ASCORBIC ACID; BRAIN CHEMISTRY; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CORPUS STRIATUM; ETHANOL; HIPPOCAMPUS; INTERNEURONS; KAINIC ACID; MALE; METHAMPHETAMINE; MICRODIALYSIS; MORPHINE; NARCOTICS; NICOTINE; NICOTINIC AGONISTS; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR;

EID: 33751520327     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.09.098     Document Type: Article

References (39)

1. Abekawa T., Ohmori T., and Koyama T. Effects of repeated administration of a high dose of methamphetamine on dopamine and glutamate release in rat striatum and nucleus accumbens. Brain Res. 643 (1994) 276-281
2. Basse-Tomusk A., and Rebec G.V. Corticostriatal and the thalamic regulation of amphetamine-induced ascorbate release in the neostriatum. Pharmacol. Biochem. Behav. 35 (1990) 55-60
3. Brazell M.P., Mitchell S.N., Joseph M.H., and Gray J.A. Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen. Neuropharmacology 29 (1990) 1177-1185
4. Brose N., O'Neill R.D., Boutelle M.G., and Fillenz M. The effects of anxiolytic and anxiogenic benzodiazepine receptor ligands on motor activity and levels of ascorbic acid in the nucleus accumbens and striatum of the rat. Neuropharmacology 28 (1989) 509-514
5. Burrows K.B., and Meshul C.K. Methamphetamine alters presynaptic glutamate immunoreactivity in the caudate nucleus and motor cortex. Synapse 27 (1997) 133-144
6. Cano-Cebrian M.J., Zornoza-Sabina T., Guerri C., Polache A., and Granero L. Acamprosate blocks the increase in dopamine extracellular levels in nucleus accumbens evoked by chemical stimulation of the ventral hippocampus. Naunyn-Schmiedebergs Arch. Pharmacol. 368 (2003) 324-327
7. Cheatwood J.L., Corwin J.V., and Reep R.L. Overlap and interdigitation of cortical and thalamic afferents to dorsocentral striatum in the rat. Brain Res. 1036 (2005) 90-100
8. Crespi F., and Keane P.E. The effect of diazepam and RO15-1788 on extracellular ascorbic acid, DOPAC and 5-HIAA in striatum of anesthetized and conscious freely moving rats, as measured by differential pulse voltammetry. Neurosci. Res. 4 (1987) 323-329
9. Di Chiara G., and Imperato A. Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats. Ann. N.Y. Acad. Sci. 473 (1986) 367-381
10. Enrico P., Esposito G., Mura M.A., Fresu L., De Natale G., Miele E., Desole M.S., and Miele M. Effects of morphine on striatal dopamine metabolism and ascorbic acid and uric acid release in freely moving rats. Brain Res. 745 (1997) 173-182
11. Grunewald R.A. Ascorbic acid in the brain. Brain Res. Rev. 18 (1993) 123-133
12. Gu P.F., Yang J.Y., Wu C.F., Li W., and Shang Y. Frontal decortication eliminates drug-induced ascorbic acid release in the striatum but not the nucleus accumbens of freely moving rats. Brain Res. 1033 (2005) 194-201
13. Heimer L., Alheid G.F., de Olmos J.S., Groenewegen H.J., Haber S.N., Harlan R.E., and Zahm D.S. The accumbens: beyond the core-shell dichotomy. In: Salloway S., Malloy P., and Cummings J.L. (Eds). The Neuropsychiatry of Limbic and Subcortical Disorders (1997), American Psychiatric Press, Washington, DC 43-70
14. Imperato A., Mulas A., and Di Chiara G. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol. 132 (1986) 337-338
15. Liu J., Wu C.F., Liu W., Zhang H.L., and Li C.L. Involvement of the corticostriatal glutamatergic pathway in ethanol-induced ascorbic acid release in rat striatum. Addict. Biol. 4 (1999) 273-281
16. Liu W., Wu C.F., Huang M., and Xiao K. Opposite effects of sulpiride and SCH 23390 on ethanol-induced striatal ascorbic acid release in intact and 6-hydroxydopamine lesioned rats. Brain Res. 869 (2000) 31-38
17. Matthews R.T., Coker O., and Winder D.G. A novel mouse brain slice preparation of the hippocampo-accumbens pathway. J. Neurosci. Methods 137 (2004) 49-60
18. Miele M., Boutelle M.G., and Fillenz M. The physiologically induced release of ascorbate in rat brain is dependent on impulse traffic, calcium influx and glutamate uptake. Neuroscience 60 (1994) 87-91
19. Miele M., Mura M.A., Enrico P., Esposito G., Serra P.A., Migheli R., Zangani D., Miele E., and Desole M.S. On the mechanism of d-amphetamine-induced changes in glutamate, ascorbic acid and uric acid release in the striatum of freely moving rats. Br. J. Pharmacol. 129 (2000) 582-588
20. Muller C.P., Carey R.J., De Souza Silva M.A., Jocham G., and Huston J.P. Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT1a-receptor antagonism blocks behavioral but potentiates serotonergic activation. Synapse 45 (2002) 67-77
21. O'Neill R.D. The measurement of brain ascorbate in vivo and its link with excitatory amino acid neurotransmission. In: Boulton A., Baker G., and Adams R.N. (Eds). Neuromethods: Voltammetric Methods in Brain Systems (1995), Humana, Clifton, NJ 221-268
22. O'Neill R.D., Grunewald R.A., Fillenz M., and Albery W.J. The effect of unilateral cortical lesions on the circadian changes in rat striatal ascorbate and homovanillic acid levels measured in vivo using voltammetry. Neurosci. Lett. 42 (1983) 105-110
23. O'Neill R.D., Fillenz M., Sundstrom L., and Rawlins J.N. Voltammetrically monitored brain ascorbate as an index of excitatory amino acid release in the unrestrained rat. Neurosci. Lett. 52 (1984) 227-233
24. Parent A., and Hazrati L.N. Functional anatomy of the basal ganglia: I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev. 20 (1995) 91-127
25. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1982), Academic Press, Sydney
26. Perez de la Mora M., Mendez-Franco J., Salceda R., Aguirre J.A., and Fuxe K. Neurochemical effects of nicotine on glutamate and GABA mechanisms in the rat brain. Acta Physiol. Scand. 141 (1991) 241-250
27. Pierce R.C., and Kumaresan V. The final common pathway for the reinforcing effect of drugs of abuse. Neurosci. Biobehav. Rev. 30 (2006) 215-238
28. Pierce R.C., and Rebec G.V. Intraneostriatal administration of glutamate antagonists increases behavioral activation and decreases neostriatal ascorbate via nondopaminergic mechanisms. J. Neurosci. 13 (1993) 4272-4280
29. Rebec G.V., and Pierce R.C. A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission. Prog. Neurobiol. 43 (1994) 537-565
30. Rebec G.V., and Wang Z. Behavioral activation in rats requires endogenous ascorbate release in striatum. J. Neurosci. 21 (2001) 668-675
31. Rice M.E. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 23 (2000) 209-216
32. Rosa K.A., Gadotti V.M., Rosa A.O., Rodrigues A.L., Calixto J.B., and Santos A.R. Evidence for the involvement of glutamatergic system in the antinociceptive effect of ascorbic acid. Neurosci. Lett. 381 (2005) 185-188
33. Shetty A.K., and Turner D.A. Glutamic acid decarboxylase-67-positive hippocampal interneurons undergo a permanent reduction in number following kainic acid-induced degeneration of CA3 pyramidal neurons. Exp. Neurol. 169 (2001) 276-297
34. Tarazi F.I., Campbell A., and Baldessarini R.J. Effects of hippocampal lesions on striatolimbic ionotropic glutamatergic receptors. Neurosci. Lett. 250 (1998) 13-16
35. Wan R.Q., Giovanni A., Kafka S.H., and Corbett R. Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies. Behav. Brain Res. 78 (1996) 211-223
36. Wu C. Possible role of glutamatergic neurotransmission in regulating ethanol-evoked brain ascorbate release. Neurosci. Lett. 171 (1994) 105-108
37. Wu C.F., Bertorelli R., Sacconi M., Pepeu G., and Consolo S. Decrease of brain acetylcholine release in aging freely-moving detected by microdialysis. Neurobiol. Aging 9 (1988) 357-361
38. Zaman V., and Shetty A.K. Combined neurotrophic supplementation and caspase inhibition enhances survival of fetal hippocampal CA3 cell grafts in lesioned CA3 region of the aging hippocampus. Neuroscience 109 (2002) 537-553
39. Zornoza T., Cano-Cebrian M.J., Miquel M., Aragon C., Polache A., and Granero L. Hippocampal dopamine receptors modulate the motor activation and the increase in dopamine levels in the rat nucleus accumbens evoked by chemical stimulation of the ventral hippocampus. Neuropsychopharmacology 30 (2005) 843-852